Corrects Q1 net income figure to $11.7 mln from $13.94 mln in Key Details table
Overview
U.S. tobacco alternatives maker's Q1 sales rose 17%, beating analyst expectations
Adjusted diluted EPS for Q1 fell to $0.76 from $0.91 last year
Company raised full-year Modern Oral sales guidance and introduced EBITDA guidance
Outlook
Turning Point Brands raises FY 2026 Modern Oral Gross Sales guidance to $280-$300 mln
Company expects FY 2026 Modern Oral Net Sales of $210-$225 mln
Turning Point Brands introduces FY 2026 Adjusted EBITDA guidance of $70-$90 mln
Result Drivers
MODERN ORAL GROWTH - Sales of Modern Oral products rose 133%, accounting for 42% of total net sales, and drove overall revenue growth
ZIG-ZAG DECLINE - Zig-Zag segment net sales fell 22.4% due to lower U.S. papers and wraps shipments
HIGHER SG&A SPENDING - Increased investment in Modern Oral sales and marketing, and higher outbound freight, led to a 53% rise in SG&A expenses
Company press release: ID:nBwbf8fkFa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Beat
$124.28 mln
$115.66 mln (5 Analysts)
Q1 Net Income
$11.7 mln
Q1 Gross Profit
$68.30 mln
Q1 Operating income
$12.48 mln
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)